Efficacy News and Research

RSS

Your unique microbiome may be used to improve and personalize your future medical experience

Study explores the potential of microbiomes in personalized medicine, focusing on diagnostics, precision therapy, and the challenges in implementing microbiome-based interventions.

27 Dec 2023

Attitudes toward pet vaccination may be linked with human vaccine hesitancy

Texas A&M University School of Public Health research on attitudes toward pet vaccination and how they may be linked with human vaccine hesitancy was the subject of a new study recently published in the journal Vaccine.

25 Dec 2023

Citrus supplement may ease knee swelling and pain after surgery

For patients undergoing total knee arthroplasty (TKA), treatment with diosmin – a flavonoid supplement derived from citrus fruits –reduced swelling of the knee and leg and some measures of associated pain can be achieved, reports a clinical trial in The Journal of Bone & Joint Surgery.

22 Dec 2023

Monkey stem cells made easy: New method unveils xeno-free, efficient culture system

Non-human primates (NHPs) have a high degree of similarity to humans compared to other animal models.

22 Dec 2023

St. Jude researchers crack the code of the β2-adrenergic receptor

Through an international collaboration, scientists at St. Jude Children's Research Hospital leveraged data science, pharmacology and structural information to conduct an atomic-level investigation into how each amino acid in the receptor that binds adrenaline contributes to receptor activity in the presence of this natural ligand.

22 Dec 2023

R21/Matrix-M vaccine gets WHO green light for global rollout

The R21/Matrix-M™ malaria vaccine is one step closer to mass rollout, after officially receiving WHO prequalification status, making it eligible for procurement by United Nations agencies.

21 Dec 2023

Low-magnification narrow-band imaging takes gastric cancer screening to the next level

Helicobacter pylori infection is recognized as a significant risk factor for gastric cancer. Hence regular screening for early detection is particularly crucial in regions with a high prevalence.

21 Dec 2023

Brazilian review explores emerging therapies for advanced Hodgkin lymphoma

A new review paper was published in Oncotarget's Volume 14 on December 12, 2023, entitled, "Current perspectives on the management of refractory or relapsed classic Hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability."

20 Dec 2023

How a malaria drug may hold the key to ending malnutrition's cycle of devastation

Wars, drought, displacement, and instability are causing a dramatic increase in the number of pregnant and breastfeeding women around the world who suffer from malnutrition.

20 Dec 2023

NHS COVID-19 app study shows digital contact tracing's effectiveness in predicting virus transmission risks

A comprehensive study in the Nature journal analyzed over seven million data points from the NHS COVID-19 app, revealing how digital contact tracing can effectively predict SARS-CoV-2 transmission risks based on exposure duration and proximity.

20 Dec 2023

Hip-focused physical therapy provides faster low back pain relief in older adults

When the University of Delaware's Gregory Hicks started his research career two decades ago, he was one of only a few people in the United States studying chronic low back pain in people over 60 years old.

19 Dec 2023

Scientists design non-hallucinogenic psychedelic treatments potentially accelerating research on mental health benefits

Researchers identified 5-hydroxytryptamine 2A (5-HT2A) receptor (5-HT2AR) signaling pathways associated with psychedelic potential.

19 Dec 2023

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Amidst a backdrop of industry-wide hurdles like inflation, talent scarcities, and stringent regulatory landscapes, Nona Biosciences is showing great promise as an emerging global leader in biotechnology.

From Nona BioSciences 19 Dec 2023

Mice with humanized immune systems test new cancer therapeutic approach that blindfolds immune cells to the body’s self-recognition system

Researchers investigated the anticancer effects of drugs targeting human tumor-associated macrophages (TAMs) in vivo. In humanized murine models, they tested the effectiveness of an antibody to human signal regulatory protein alpha (SIRPα) for cancer immunotherapy.

19 Dec 2023

Digital algorithm ePOCT+ successfully reduces antibiotic prescriptions in children, combating antimicrobial resistance

Study demonstrates how the ePOCT+ digital algorithm effectively guides healthcare providers in prescribing antibiotics for children, significantly reducing unnecessary antibiotic use and addressing antimicrobial resistance without compromising patient outcomes.

18 Dec 2023

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants like XBB.1.5, demonstrating its potential as a broadly effective and stable vaccine option.

18 Dec 2023

€7.4M EU grant boosts development of vaccines against Marburg viruses

International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.

18 Dec 2023

EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures

...

From Zeus Inc. 18 Dec 2023

Psilocybin may benefit individuals with cancer and major depression

Results from a phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psiloybe, may benefit individuals with cancer and major depression.

18 Dec 2023

Study reveals connection between early-life diseases and childlessness

Led by Aoxing Liu and senior authors Melinda Mills, Andrea Ganna and an international team, the study examined the link between 414 early-life diseases and lifetime childlessness in over 2.5 million individuals born in Finland and Sweden.

18 Dec 2023

Efficacy News and Research

Your unique microbiome may be used to improve and personalize your future medical experience

Attitudes toward pet vaccination may be linked with human vaccine hesitancy

Citrus supplement may ease knee swelling and pain after surgery

Monkey stem cells made easy: New method unveils xeno-free, efficient culture system

St. Jude researchers crack the code of the β2-adrenergic receptor

R21/Matrix-M vaccine gets WHO green light for global rollout

Low-magnification narrow-band imaging takes gastric cancer screening to the next level

Brazilian review explores emerging therapies for advanced Hodgkin lymphoma

How a malaria drug may hold the key to ending malnutrition's cycle of devastation

NHS COVID-19 app study shows digital contact tracing's effectiveness in predicting virus transmission risks

Hip-focused physical therapy provides faster low back pain relief in older adults

Scientists design non-hallucinogenic psychedelic treatments potentially accelerating research on mental health benefits

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Mice with humanized immune systems test new cancer therapeutic approach that blindfolds immune cells to the body’s self-recognition system

Digital algorithm ePOCT+ successfully reduces antibiotic prescriptions in children, combating antimicrobial resistance

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

€7.4M EU grant boosts development of vaccines against Marburg viruses

EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures

Psilocybin may benefit individuals with cancer and major depression

Study reveals connection between early-life diseases and childlessness

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News